Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality.
about
The Myocardial Ischemia Reduction with Acute Cholesterol Lowering trial: MIRACuLous or not, it's time to change current practice.Impact of a cardiac risk reduction program in vulnerable patients hospitalized with coronary artery diseaseThe use of lipid-lowering therapy for secondary prevention in patients undergoing percutaneous coronary interventionPractising what is preached: the MINAP studyEpithelial neutrophil-activating peptide (ENA-78), acute coronary syndrome prognosis, and modulatory effect of statinsGNAS gene variants affect β-blocker-related survival after coronary artery bypass grafting.Missed opportunities for osteoporosis treatment in patients hospitalized for hip fracture.Benefits of statin therapy and compliance in high risk cardiovascular patients.A comparison of clinical outcome studies among cholesterol-lowering agents.Clinical outcomes associated with proton pump inhibitor use among clopidogrel-treated patients within CYP2C19 genotype groups following acute myocardial infarction.Early statin therapy for acute coronary syndromes.The importance of in-hospital statin therapy for patients with acute coronary syndromes.Adherence to statin treatment following a myocardial infarction: an Italian population-based survey.Statin use after acute myocardial infarction: a nationwide study in DenmarkVitamin D dependent effects of APOA5 polymorphisms on HDL cholesterolCase-Only Survival Analysis Reveals Unique Effects of Genotype, Sex, and Coronary Disease Severity on Survivorship.The electronic health record--the time is now.The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review.Intensification of diabetes medication and risk for 30-day readmission.Effect of early statin treatment in patients with cardiogenic shock complicating acute myocardial infarctionAdrenergic-pathway gene variants influence beta-blocker-related outcomes after acute coronary syndrome in a race-specific mannerMissed opportunities for secondary prevention of cerebrovascular disease in elderly British men from 1999 to 2005: a population-based study.Statins and coronary artery bypass graft surgery: preoperative and postoperative efficacy and safety.Non-adherence to statin therapy: a major challenge for preventive cardiology.Who needs laboratories and who needs statins?: comparative and cost-effectiveness analyses of non-laboratory-based, laboratory-based, and staged primary cardiovascular disease screening guidelinesSurgeons save bones: an algorithm for orthopedic surgeons managing secondary fracture prevention.The need for a national infrastructure to improve the rational use of therapeutics.Patients with acute coronary syndrome should start a statin while still in hospital.Perspectives: NCEP III-A Call to Arms!Non-attendance at secondary prevention clinics: the effect on lipid management.Mortality reduction benefits of a comprehensive cardiac care program for patients with occlusive coronary artery disease.Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction.Clinically feasible stratification of 1-year to 3-year post-myocardial infarction risk.
P2860
Q24794251-E0510C77-9167-4F65-9A03-B4C00D4477A8Q28169132-8127EDA2-5848-41BD-9B91-6CD41F2734B5Q28196775-5AEDAC08-7CBF-4117-B49F-78243F39C654Q28211003-8F224B9D-2C58-4C9D-A1CD-80CA8658A62EQ28385323-21367BB0-7E90-459C-B4B7-41B42F5C69D8Q33803705-45B97E77-52AB-4B2F-ABB6-E07B0A3583A6Q33805602-1C44E7BE-5356-4E11-B7BE-DB3EBB77B58DQ34187551-8D24F1C0-EBBB-46DF-816F-08E47198031CQ34495746-6607F95A-299B-4CC2-B44E-B66F8DB37598Q34873839-FB88D570-2394-4F3A-BFF4-EFE6C325F8BCQ34979669-283465CE-EAA5-44E8-8FD6-B47229E1167CQ35101478-03B5743C-F2CE-43E9-82E1-A6F72A27E2C2Q35687652-76D01F7C-B41B-4BCB-8630-C2D8C2A8C5D3Q35827170-63B7C90D-CEF5-4A36-9CF2-582B1EEBF1A0Q35907312-71FF7A1D-0635-4823-A40C-40C283160B5CQ36019880-59EE4447-3D57-44FA-8C59-EACA4DA40A78Q36232827-3761CB3E-7F46-4637-B10A-D100187A8DEDQ36432150-165E0454-75F6-41CF-B707-F373458921B4Q36553490-0F68C2A8-331A-4631-A1FD-BF17D1FF1EB6Q36681810-BB9EC55D-1428-4658-917F-525EA31A61DEQ36919549-52801354-71BE-43C5-9BEF-7F1A7D7C51F5Q37297492-9DAA1660-716A-493F-8370-DBD9385D6C5CQ37578459-79F703D9-101C-485D-8009-C14837FADAA7Q37642755-4FF89733-F21D-4D04-8AA6-FFEEDDF0D8B3Q37677821-14D90D8E-D986-4562-A429-FDCF641664B2Q38107423-42686F65-5981-4901-976B-EB218ABFFC17Q38468151-0FEDBBBC-ED86-42B8-BD15-325D1D3FFFA3Q42700220-F1F0F699-CCA2-4623-93D5-DFC7DCF449B1Q46408543-C02355BC-4EB1-4506-BB98-A964CE881FB3Q46565750-B6B6CD0E-4F29-4359-B0F3-44C0EFBA30A5Q46981071-7965B1DF-D2BE-4E2F-A4D9-80B95751396DQ51825004-AAFB2E2E-9B1C-4526-95FF-D0B8A5ADC5CFQ52659267-CE797B69-11BB-4E20-A063-4AB21047B4D8
P2860
Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Usefulness of in-hospital pres ...... pliance and reduced mortality.
@ast
Usefulness of in-hospital pres ...... pliance and reduced mortality.
@en
type
label
Usefulness of in-hospital pres ...... pliance and reduced mortality.
@ast
Usefulness of in-hospital pres ...... pliance and reduced mortality.
@en
prefLabel
Usefulness of in-hospital pres ...... pliance and reduced mortality.
@ast
Usefulness of in-hospital pres ...... pliance and reduced mortality.
@en
P2093
P1476
Usefulness of in-hospital pres ...... pliance and reduced mortality.
@en
P2093
Anderson JL
Muhlestein JB
Pearson RR
P304
P356
10.1016/S0002-9149(00)01354-0
P407
P577
2001-02-01T00:00:00Z